Publications

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

 168
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Next Article

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base

Ultrapotent SARS coronavirus-neutralizing single-domain...

 124

Structural basis of apoptosis induction by the mitochondrial voltage-dependent anion channel

Structural basis of apoptosis induction by the mitochon...

 57

Age-associated changes in transcriptional elongation and their effects on homeostasis

Age-associated changes in transcriptional elongation an...

 163